The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

Matthew Bott, Marie Brevet, Barry S. Taylor, Shigeki Shimizu, Tatsuo Ito, Lu Wang, Jenette Creaney, Richard A. Lake, Maureen F. Zakowski, Boris Reva, Chris Sander, Robert Delsite, Simon Powell, Qin Zhou, Ronglai Shen, Adam Olshen, Valerie Rusch, Marc Ladanyi

Research output: Contribution to journalArticle

373 Citations (Scopus)

Abstract

Malignant pleural mesotheliomas (MPMs) often show CDKN2A and NF2 inactivation, but other highly recurrent mutations have not been described. To identify additional driver genes, we used an integrated genomic analysis of 53 MPM tumor samples to guide a focused sequencing effort that uncovered somatic inactivating mutations in BAP1 in 23% of MPMs. The BAP1 nuclear deubiquitinase is known to target histones (together with ASXL1 as a Polycomb repressor subunit) and the HCF1 transcriptional co-factor, and we show that BAP1 knockdown in MPM cell lines affects E2F and Polycomb target genes. These findings implicate transcriptional deregulation in the pathogenesis of MPM.

Original languageEnglish
Pages (from-to)668-672
Number of pages5
JournalNature Genetics
Volume43
Issue number7
DOIs
Publication statusPublished - Jul 2011
Externally publishedYes

Fingerprint

Mutation
Histones
Genes
Deubiquitinating Enzymes
Malignant Mesothelioma
Cell Line
Neoplasms

ASJC Scopus subject areas

  • Genetics

Cite this

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. / Bott, Matthew; Brevet, Marie; Taylor, Barry S.; Shimizu, Shigeki; Ito, Tatsuo; Wang, Lu; Creaney, Jenette; Lake, Richard A.; Zakowski, Maureen F.; Reva, Boris; Sander, Chris; Delsite, Robert; Powell, Simon; Zhou, Qin; Shen, Ronglai; Olshen, Adam; Rusch, Valerie; Ladanyi, Marc.

In: Nature Genetics, Vol. 43, No. 7, 07.2011, p. 668-672.

Research output: Contribution to journalArticle

Bott, M, Brevet, M, Taylor, BS, Shimizu, S, Ito, T, Wang, L, Creaney, J, Lake, RA, Zakowski, MF, Reva, B, Sander, C, Delsite, R, Powell, S, Zhou, Q, Shen, R, Olshen, A, Rusch, V & Ladanyi, M 2011, 'The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma', Nature Genetics, vol. 43, no. 7, pp. 668-672. https://doi.org/10.1038/ng.855
Bott, Matthew ; Brevet, Marie ; Taylor, Barry S. ; Shimizu, Shigeki ; Ito, Tatsuo ; Wang, Lu ; Creaney, Jenette ; Lake, Richard A. ; Zakowski, Maureen F. ; Reva, Boris ; Sander, Chris ; Delsite, Robert ; Powell, Simon ; Zhou, Qin ; Shen, Ronglai ; Olshen, Adam ; Rusch, Valerie ; Ladanyi, Marc. / The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. In: Nature Genetics. 2011 ; Vol. 43, No. 7. pp. 668-672.
@article{a31be109973a41a3b768a803d598b7b4,
title = "The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma",
abstract = "Malignant pleural mesotheliomas (MPMs) often show CDKN2A and NF2 inactivation, but other highly recurrent mutations have not been described. To identify additional driver genes, we used an integrated genomic analysis of 53 MPM tumor samples to guide a focused sequencing effort that uncovered somatic inactivating mutations in BAP1 in 23{\%} of MPMs. The BAP1 nuclear deubiquitinase is known to target histones (together with ASXL1 as a Polycomb repressor subunit) and the HCF1 transcriptional co-factor, and we show that BAP1 knockdown in MPM cell lines affects E2F and Polycomb target genes. These findings implicate transcriptional deregulation in the pathogenesis of MPM.",
author = "Matthew Bott and Marie Brevet and Taylor, {Barry S.} and Shigeki Shimizu and Tatsuo Ito and Lu Wang and Jenette Creaney and Lake, {Richard A.} and Zakowski, {Maureen F.} and Boris Reva and Chris Sander and Robert Delsite and Simon Powell and Qin Zhou and Ronglai Shen and Adam Olshen and Valerie Rusch and Marc Ladanyi",
year = "2011",
month = "7",
doi = "10.1038/ng.855",
language = "English",
volume = "43",
pages = "668--672",
journal = "Nature Genetics",
issn = "1061-4036",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

AU - Bott, Matthew

AU - Brevet, Marie

AU - Taylor, Barry S.

AU - Shimizu, Shigeki

AU - Ito, Tatsuo

AU - Wang, Lu

AU - Creaney, Jenette

AU - Lake, Richard A.

AU - Zakowski, Maureen F.

AU - Reva, Boris

AU - Sander, Chris

AU - Delsite, Robert

AU - Powell, Simon

AU - Zhou, Qin

AU - Shen, Ronglai

AU - Olshen, Adam

AU - Rusch, Valerie

AU - Ladanyi, Marc

PY - 2011/7

Y1 - 2011/7

N2 - Malignant pleural mesotheliomas (MPMs) often show CDKN2A and NF2 inactivation, but other highly recurrent mutations have not been described. To identify additional driver genes, we used an integrated genomic analysis of 53 MPM tumor samples to guide a focused sequencing effort that uncovered somatic inactivating mutations in BAP1 in 23% of MPMs. The BAP1 nuclear deubiquitinase is known to target histones (together with ASXL1 as a Polycomb repressor subunit) and the HCF1 transcriptional co-factor, and we show that BAP1 knockdown in MPM cell lines affects E2F and Polycomb target genes. These findings implicate transcriptional deregulation in the pathogenesis of MPM.

AB - Malignant pleural mesotheliomas (MPMs) often show CDKN2A and NF2 inactivation, but other highly recurrent mutations have not been described. To identify additional driver genes, we used an integrated genomic analysis of 53 MPM tumor samples to guide a focused sequencing effort that uncovered somatic inactivating mutations in BAP1 in 23% of MPMs. The BAP1 nuclear deubiquitinase is known to target histones (together with ASXL1 as a Polycomb repressor subunit) and the HCF1 transcriptional co-factor, and we show that BAP1 knockdown in MPM cell lines affects E2F and Polycomb target genes. These findings implicate transcriptional deregulation in the pathogenesis of MPM.

UR - http://www.scopus.com/inward/record.url?scp=79959694149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959694149&partnerID=8YFLogxK

U2 - 10.1038/ng.855

DO - 10.1038/ng.855

M3 - Article

C2 - 21642991

AN - SCOPUS:79959694149

VL - 43

SP - 668

EP - 672

JO - Nature Genetics

JF - Nature Genetics

SN - 1061-4036

IS - 7

ER -